Geode Capital Management LLC raised its position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 4.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,429,078 shares of the company’s stock after purchasing an additional 104,935 shares during the period. Geode Capital Management LLC’s holdings in Astera Labs were worth $403,598,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Royal Bank of Canada increased its stake in shares of Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares during the last quarter. Empowered Funds LLC increased its stake in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the last quarter. First Trust Advisors LP increased its stake in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. increased its stake in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after purchasing an additional 1,977 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Astera Labs Trading Up 0.1%
Astera Labs stock opened at $343.05 on Monday. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $354.53. The firm has a market capitalization of $58.80 billion, a price-to-earnings ratio of 231.79, a P/E/G ratio of 4.54 and a beta of 3.94. The firm has a 50 day simple moving average of $190.82 and a 200 day simple moving average of $165.06.
Insider Activity at Astera Labs
In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This trade represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,306,257 shares of company stock worth $473,685,936. Corporate insiders own 10.40% of the company’s stock.
Wall Street Analyst Weigh In
ALAB has been the subject of several research analyst reports. UBS Group initiated coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target for the company. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, Susquehanna lifted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.
Get Our Latest Stock Analysis on Astera Labs
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Further Reading
- Five stocks we like better than Astera Labs
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
